Neonatal CPB Anticoagulation: Initial Heparin Dose in a Randomized Trial
A 76-neonate randomized trial compared initial heparin doses during CPB. Higher initial dosing improved ACT response and a thrombin-generation marker, but clinical benefit and
Oct 21, 2026